GORACCI, ARIANNA
 Distribuzione geografica
Continente #
EU - Europa 9.733
NA - Nord America 7.515
AS - Asia 2.895
SA - Sud America 503
AF - Africa 77
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.753
Nazione #
US - Stati Uniti d'America 7.416
RU - Federazione Russa 3.250
IT - Italia 1.754
GB - Regno Unito 1.745
CN - Cina 1.143
SG - Singapore 963
IE - Irlanda 849
SE - Svezia 482
UA - Ucraina 440
BR - Brasile 432
DE - Germania 294
HK - Hong Kong 252
FR - Francia 248
FI - Finlandia 175
PL - Polonia 174
KR - Corea 119
VN - Vietnam 118
ES - Italia 115
IN - India 72
NL - Olanda 68
JP - Giappone 63
CA - Canada 60
TR - Turchia 32
MX - Messico 29
AR - Argentina 26
BD - Bangladesh 26
CH - Svizzera 24
AU - Australia 23
BE - Belgio 18
IQ - Iraq 18
AT - Austria 17
IR - Iran 16
ZA - Sudafrica 16
CI - Costa d'Avorio 13
PK - Pakistan 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
EG - Egitto 11
MY - Malesia 11
GR - Grecia 9
PT - Portogallo 9
MA - Marocco 8
RO - Romania 8
SA - Arabia Saudita 8
UY - Uruguay 8
CL - Cile 7
HU - Ungheria 7
VE - Venezuela 7
DK - Danimarca 6
KE - Kenya 5
TN - Tunisia 5
UG - Uganda 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
LU - Lussemburgo 4
PE - Perù 4
PH - Filippine 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
GT - Guatemala 3
ID - Indonesia 3
KZ - Kazakistan 3
NO - Norvegia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
Totale 20.740
Città #
Southend 1.609
Dublin 840
Dallas 779
Fairfield 748
Ashburn 708
Houston 582
Singapore 520
Chandler 470
Moscow 385
Santa Clara 383
Woodbridge 372
Jacksonville 352
Beijing 329
Seattle 285
Wilmington 275
Cambridge 245
Hong Kong 241
Ann Arbor 208
Siena 167
Princeton 150
Hefei 138
Seoul 115
Nanjing 108
Rome 105
Milan 98
Los Angeles 96
Helsinki 90
Málaga 89
Florence 72
San Mateo 70
Boardman 61
Washington 58
Warsaw 53
Dong Ket 52
The Dalles 52
New York 51
Munich 49
Nanchang 43
San Diego 43
Tianjin 37
Menlo Park 35
São Paulo 34
Buffalo 33
Columbus 30
Council Bluffs 30
Shenyang 30
Norwalk 28
London 26
Brooklyn 25
Ho Chi Minh City 25
Hebei 23
Naples 23
Redondo Beach 23
Dearborn 22
Jiaxing 22
Bologna 20
Palermo 20
Prato 20
San Francisco 19
Belo Horizonte 18
Brussels 18
Stockholm 18
Kunming 17
Montreal 17
Changsha 16
Jinan 16
Trento 16
Turku 16
Bengaluru 15
Chicago 15
Fremont 15
Hanoi 15
Redwood City 15
Brescia 14
Chennai 14
Guangzhou 14
Nuremberg 14
Shanghai 14
Abidjan 13
Catania 13
Rio de Janeiro 13
Tokyo 13
Toronto 13
Zhengzhou 13
Cagliari 12
Curitiba 12
Krakow 12
Latina 12
Mestre 12
Verona 12
Vienna 12
Cascina 11
Düsseldorf 11
Frankfurt am Main 11
Denver 10
Genoa 10
Pisa 10
Salvador 10
Turin 10
Atlanta 9
Totale 12.167
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.655
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 502
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 406
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 387
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 375
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 328
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 285
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 273
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 267
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 264
Mood stabilisers and pregnancy outcomes - a review 259
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 256
P.1.k.034 Psychomotor agitation in emergency medicine settings 256
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 244
Mood disorders and bariatric surgery: a pilot study 241
Liraglutide in psychiatric patients: preliminary results 241
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 240
Drug safety evaluation of aripiprazole in bipolar disorder 236
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 236
Telepsychiatry: new perspectives and open issues 235
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 233
Early warning symptoms of schizophrenia 221
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 219
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 214
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 214
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 214
Advances in treatment for postpartum major depressive disorder 214
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 211
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 208
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 205
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 203
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 202
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 200
Quality of life, anxiety and depression in Sarcoidosis 198
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 196
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 196
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 192
Quality of life and sub threshold affective symptoms 188
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 184
Clinica della mania 183
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 183
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 182
Infertility and psychiatric morbidity 181
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 180
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 179
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 177
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 176
Quality of life and subthreshold obsessive-compulsive disorder 174
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 174
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 173
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 173
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 172
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 171
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 170
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 170
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 169
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 165
Spettro dell'umore e sindrome metabolica 162
The long term-maximising potential for rehabilitation in patients with schizophrenia 161
Social cognition in people with schizophrenia: a cluster-analytic approach 161
Accuracy of self-assessment of real-life functioning in schizophrenia 160
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 159
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 159
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 159
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 157
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 155
null 155
Pharmacotherapy of binge-eating disorder: a review 153
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 152
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 152
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 151
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 150
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 147
Quetiapine in post-transplant acute mania/bipolar disorder NOS 144
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 144
Psicopatologia della mania: dimensioni fenomenologiche 134
null 134
What can we learn from the large US Cohort study (STEP-BD) 134
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 126
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 125
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 124
Physical activity and mental health, psychological and physiological mechanisms 120
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 119
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 119
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 113
Human CRY1 variants associate with attention deficit/hyperactivity disorder 113
Interazione tra farmaci 112
Binge eating disorder: from clinical research to clinical practice 112
Practical guidance for prescribing trazodone extended-release in major depression 112
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 109
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 109
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 108
null 106
Pharmacokinetic Interactions 102
null 100
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 91
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 85
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 84
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 83
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 80
Totale 20.785
Categoria #
all - tutte 59.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.422 0 0 0 0 0 216 136 252 205 263 165 185
2021/20221.363 83 140 123 135 97 47 88 101 129 119 71 230
2022/20233.864 98 141 247 239 172 330 62 192 2.119 117 89 58
2023/20241.934 80 55 188 100 140 501 509 64 29 62 80 126
2024/20253.188 97 201 280 259 392 230 118 132 324 140 343 672
2025/20263.887 566 813 546 647 1.270 45 0 0 0 0 0 0
Totale 21.057